Reuters: Moderna expects COVID-19 vaccine trial data for children aged 2-5 in March

Reuters: Moderna expects COVID-19 vaccine trial data for children aged 2-5 in March. “Moderna Inc said on Wednesday it expects to report data from its COVID-19 vaccine trial in children aged between 2 to 5 years in March.”

Leave a Reply

%d bloggers like this: